Addition of Metastasis-Directed Therapy to Standard of Care: Primary Aggregate Analysis and Immunologic Correlatives of the Phase II Randomized EXTEND Trial

Category Primary study
ConferenceInternational Journal of Radiation Oncology Biology Physics
Year 2025
This article has no abstract
Epistemonikos ID: c431988b48d6a6aa84ad6763176a6df2efd03863
First added on: Oct 24, 2025